인쇄하기
취소

GSK to sue 3 domestic firms for Zofran business damages.

Published: 2004-03-23 07:00:00
Updated: 2004-03-23 07:00:00
The patent dispute on finasteride (a drug for the treatment of prostatomegaly), between Choongwe and MSD has not been smoothly solved but appealed to the Seoul High Court. Amid this atmosphere, GSK recently raised a lawsuit against 3 Korean companies for Zofran (ondansetron: anti-vomiting drug) patent infringement along with its compensation for the business damages.

The patent of ondanset...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.